Terumo Corporation - FDA 510(k) Cleared Devices
13
Total
13
Cleared
0
Denied
Terumo Corporation has 13 FDA 510(k) cleared medical devices. Based in Shibuya-Ku, Tokyo, JP.
Latest FDA clearance: Mar 2026. Active since 2012. Primary specialty: Cardiovascular.
Browse the FDA 510(k) cleared devices submitted by Terumo Corporation Filter by specialty or product code using the sidebar.
FDA 510(k) cleared devices by Terumo Corporation
13 devices
Cleared
Mar 27, 2026
Ryurei
Cardiovascular
247d
Cleared
Nov 21, 2025
Pen Injector Needle 32.5
General Hospital
259d
Cleared
Jul 17, 2025
DualView Catheter
Cardiovascular
127d
Cleared
Nov 26, 2024
R2P Radifocus Glidewire Advantage
Cardiovascular
246d
Cleared
Aug 21, 2024
Glidewire GT-R
Cardiovascular
146d
Cleared
Jul 18, 2019
Immucise
General Hospital
146d
Cleared
Nov 13, 2018
Immucise Intradermal Injection System
General Hospital
174d
Cleared
Mar 29, 2018
NaviCross 0.018
Cardiovascular
105d
Cleared
Sep 15, 2017
Glidewire GT
Cardiovascular
217d
Cleared
Mar 13, 2013
CAPIOX FX HOLLOW FIBER OXYGENATOR W/ RESERVOIR
Cardiovascular
36d
Cleared
Mar 13, 2013
CAPIOX RX05 HOLLOW FIBER OXYGENATOR/RESERVOIR
Cardiovascular
15d
Cleared
Sep 05, 2012
TERUMO SURFLASH SAFETY I.V. CATHETER
General Hospital
15d